www.pharmablog.nl

Weblog met nieuws over de pharmaceutische industrie

Archive for September, 2009

Research aimed at developing drugs that stop malaria parasites from spreading throughout the body has seen Dr Jake Baum, from the Walter and Eliza Hall Institute, named a Young Tall Poppy by the Australian Institute of Policy and Science. Dr Baum, a senior postdoctoral fellow in the institute’s Infection and Immunity division, is investigating the molecular mechanisms that control the malaria parasite’s movement.
Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Scientists at Georgia State University have uncovered the mechanisms of how pain in infancy alters how the brain processes pain in adulthood. Research is now indicating that infants who spent time in the neonatal intensive care unit (NICU) show altered pain sensitivity in adolescence. These results have profound implications and highlight the need for pre-emptive and post-operative pain medicine for newborn infants.
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Regenerative medicine researchers at the University of Pittsburgh received two grants totaling more than $5 million from the National Institutes of Health (NIH) to explore new methods for cultivating replacement cells from existing tissues and organs. A $2.
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Yale engineers have for the first time observed and tracked E. coli bacteria moving in a liquid medium with a motion similar to that of a kayak paddle. Their findings, which appear online September 29 in the journal Physical Review Letters, will help lead to a better understanding of how bacteria move from place to place and, potentially, how to keep them from spreading. Scientists have long theorized that the cigar-shaped cell bodies of E.
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Insulin resistance, the hallmark of type 2 diabetes and a condition often associated with obesity, is paradoxically also an apparent contributor to muscle wasting and severe fat loss that accompanies some cancers, according to new research. And in an animal study, a diabetes drug that promotes insulin sensitivity slowed the progression of muscle wasting and fat loss, the main consequences of a syndrome called cachexia, in mice with colon cancer tumors.
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • The National Science Foundation has awarded $431,200 to the University of Alabama at Birmingham (UAB) Department of Physics to facilitate the purchase of a new highly-specialized imaging system - the first of its kind in Alabama - that will be a centerpiece of a new interdisciplinary research laboratory on campus. Project directors, including physicists Andrei Stanishevsky, Ph.D., and Yogesh Vohra, Ph.D.
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Camille Harris of Ridgeland, Mississippi, a graduate student in biological sciences at Virginia Tech, has been awarded a National Institutes of Health (NIH) Graduate Research Fellowship for her study of forest disturbance and its ecological impacts on LaCrosse Virus, a mosquito-borne disease that can cause seizures, coma, paralysis, and permanent brain damage in severe cases. Harris, a wildlife veterinarian, is pursuing her doctoral degree.
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • The Senate Finance Committee on Thursday defeated an amendment that sought to squeeze more money out of pharmaceutical companies to help pay for the costs of changing the health care system. The panel’s vote was a victory for President Obama and Finance Chairman Max Baucus.
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Kaiser Permanente said late Monday that a unit of the federal Department of Health and Human Services has given it a $1 million, three-year grant to help fund its internal Simulation Program, which lets nurses and other caregivers practice life-saving skills and decision making in a simulated environment.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Maxygen Inc. named a new CEO, extended a consulting agreement with a private investment firm led by its executive chairman and beefed up non-employee board members’ compensation. (MAXY)

    Lees meer..

  • 0 Comments
  • Filed under: 3